Pyrazolo[1,5-a]pyrimidines for antiviral treatment
US8486938B2 · kind B2 · utility
14Cited by
0References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 23, 2011 |
| Grant date | Jul 16, 2013 |
| Priority date | — |
| Expiry date | Jul 26, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides compounds of Formula I or Formula II:or a pharmaceutically acceptable salt or ester, thereof, as described herein. The compounds and compositions thereof are useful for treating Pneumovirinae virus infections. The compounds, compositions, and methods provided are particularly useful for the treatment of Human respiratory syncytial virus infections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.